Form 8-K
Please expand your disclosures to clearly define each of the Non GAAP measures you present. In doing so, please ensure your disclosures clearly explain the nature and the reasons for each of the adjustments included in arriving at the Non GAAP measures presented.
We acknowledge the Staff's comment and understand the need for transparency in our disclosures of non-GAAP financial measures. In future filings, we will more clearly define each non-GAAP financial measure presented and more clearly explain the nature of and reasons for each adjustment. Read in the reply ↗
Please revise to disaggregate your goodwill from intangibles on the face of your balance sheet (refer to ASC 350-20-45-1) to clearly delineate the balance of goodwill (nonamortizable) from other intangible assets. Please also expand your footnotes to include the disclosures required in ASC 350-20-50-1 by reportable segment.
In future filings, we will revise the face of the balance sheet to clearly delineate goodwill and align our disclosure within the applicable financial statement footnote with the requirements of ASC 350-20-50-1 as it relates to our reporting segments, including the presentation of the gross amount of goodwill and accumulated impairment losses and any changes in the carrying amounts during the period. Read in the reply ↗
Please show earnings from equity investments as a separate line item in your statement of operations or tell us why your presentation is appropriate. Please refer to Rule 5-03(b)(12) of Regulation S-X. 10. Other assets and accrued and other liabilities, page 62
In future filings, we will disaggregate earnings from equity investments as a separate line item in our statement of operations in accordance with Rule 5-03(b)(12) of Regulation S-X and will adjust our presentation within the applicable financial statement footnote to conform with this disaggregation.
10. Other assets and accrued and other liabilities, page 62 Read in the reply ↗
We note that within your accrued and other liabilities, there was approximately $351 million and $324 million as of December 31, 2022 and December 31, 2021 respectively related to "Other" liabilities. Such amounts represented approximately 21% of the total accrued and other liabilities balance and approximately 6% of total liabilities for each of the periods presented.Rest of the question
In future filings, please expand your disclosures to provide additional clarity related to the underlying components included within such balances. 11. Commitments and contingencies, page 63
We confirm that there were no individual balances within "Other" liabilities that exceeded 5% of total liabilities at either December 31, 2022 or December 31, 2021. In future filings, we will expand our disclosures surrounding balances included within "Other" liabilities to provide additional clarity related to the underlying components.
11. Commitments and contingencies, page 63 Read in the reply ↗
In future filings, please expand your disclosures to highlight any amounts recognized related to CDD liabilities for each of the periods presented.
We acknowledge the Staff's comment and confirm that there were no such liabilities at either December 31, 2022 or December 31, 2021. In future filings, we will expand our disclosures as needed based on our consolidated balances of CDD liabilities.
We acknowledge that PulteGroup, Inc. is responsible for the accuracy and adequacy of our disclosures, notwithstanding any review, comments, action, or absence of action by the Staff.
We would welcome the opportunity to discuss any questions you may have regarding this response at your convenience. You may contact me at (404) 978-6417. Read in the reply ↗
Also in this review: closing letter, 2023-03-20